Clinical Chemistry and Laboratory Medicine (CCLM)· 2026Q1
Delivering the EU Safe Hearts Plan: the essential role of laboratory medicine in cardiovascular health
- 0citations
- Q1SCImago
- 2026year
Short summary
Laboratory medicine must be central to the EU Safe Hearts Plan, providing harmonized data for risk assessment, diagnosis, treatment guidance, and monitoring to achieve equitable cardiovascular health gains.
AI-generated from the title and abstract; the full text is not read.
Key points
- Laboratory medicine is a central component for the EU Safe Hearts Plan's success.
- Harmonized lab data are vital for risk assessment, diagnosis, treatment, and monitoring.
- The plan advocates for tiered, personalized testing integrating established and emerging biomarkers.
- Five key priorities include governance, personalized pathways, equitable access, clinical linkage, and innovation.
AI-generated from the title and abstract; the full text is not read.
Abstract
Abstract The European Union Safe Hearts Plan provides an opportunity to strengthen cardiovascular prevention, early detection, treatment, and monitoring across Europe. This EFLM position paper argues that laboratory medicine must be recognized as a central component of its implementation. Reliable and harmonized laboratory data underpin cardiovascular risk assessment, diagnosis, therapeutic guidance, longitudinal monitoring, and evaluation of population outcomes. Beyond the minimum health-check dataset, tiered and personalized pathways should integrate established biomarkers, specialist testing, and validated emerging technologies. EFLM proposes five priorities: embedding laboratory expertise in governance; translating core testing into personalized pathways; expanding equitable access through quality-assured decentralized models; linking testing to clinical action and value-based financing; and accelerating responsible innovation while strengthening professional capability. By connecting screening with diagnosis, treatment, and measurable outcomes, laboratory medicine can provide the quality, interpretation, and data infrastructure required to transform the Safe Hearts Plan from policy ambition into equitable cardiovascular health gains across Europe.
The authors' abstract, as published at the source. Clinical Chemistry and Laboratory Medicine (CCLM), 2026 · DOI ↗
The rest is in the Pofolia app
Takeaways and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Cardiology and Cardiovascular Medicine
Cardiology and Cardiovascular MedicineMedicine